Jiang Yuzhen

Hong Kendra L, Xu Benjamin Y, Wang Wei, Cho Austin, Foster Paul J, Jiang Yuzhen et al.

Nasal iridotrabecular contact (ITC) and greater ITC length on AS-OCT predict PACS to PAC progression. Qualitative ITC assessment offers a practical, accessible method for identifying high-risk PACS eyes, streamlining clinical risk stratification.

Hong Kendra L, Xu Benjamin Y, Wang Wei, Cho Austin, Kistler Natalie M, Foster Paul J et al.

Short-term changes in lens vault and angle width predict long-term angle closure progression in PACS eyes, enhancing risk assessment beyond baseline biometrics for earlier intervention.

Chen Zidong, Yang Wenxin, Yang Yangfan, Jiang Yuzhen, Zhang Yuning, Zhang Xinyi et al.

This study found normal-tension glaucoma patients were older, female, and showed more visual field asymmetry than high-tension glaucoma, potentially worsened by IOP fluctuations.

Yang Yangfan, Xu Kezheng, Chen Zidong, Zhang Yuning, Ye Qiaona, Ping Yu-Tzu et al.

This study found most OAG/OHT patients respond well to initial and repeat SLT, with repeat SLT having a longer effect. This supports using repeat SLT regardless of initial response, though some non-responders have distinct features.

Liao Chimei, Quigley Harry, Jiang Yuzhen, Huang Shengsong, Huang Wenyong, Friedman David et al.

This study found that a smaller decrease in iris volume during pupil dilation is an additional risk factor for angle closure progression, improving prediction of disease development.

Cho Austin, Xu Benjamin Y, Friedman David S, Foster Paul J, Jiang Yu, Pardeshi Anmol A et al.

This study found static eye measurements, especially a small TISA500 in light, predict angle closure progression better than dynamic changes or dark measurements, aiding patient risk stratification.

Bao Yicheng K, Xu Benjamin Y, Friedman David S, Cho Austin, Foster Paul J, Jiang Yu et al.

This study found persistent angle narrowing after LPI, measured by AS-OCT or gonioscopy, predicts progression to angle closure. This identifies high-risk patients needing closer monitoring.

Chang Dolly Shuo-Teh, Jiang Yuzhen, Kim Julia Anne, Huang Shengsong, Munoz Beatriz, Aung Tin et al.

This study found prophylactic laser iridotomy in angle-closure suspect eyes did not cause clinically significant cataract progression or require more cataract surgery over six years, despite slightly increased lens opacity.

Xu Benjamin Y, Friedman David S, Foster Paul J, Jiang Yu, Porporato Natalia, Pardeshi Anmol A et al.

This study found that narrower anterior chamber angles and flatter irises, measured by AS-OCT, predict progression from angle closure suspect to disease, helping risk-stratify patients.

Yang Yangfan, Jiang Yuzhen, Huang Shitong, Zhang Xinyi, Nathwani Neil, Lin Mingkai et al.

This trial compared SLT versus medication as first-line glaucoma treatment in China. Baseline data showed younger, more myopic patients with worse visual fields than a similar UK study, highlighting population differences in glaucoma presentation.

Xu Benjamin Y, Friedman David S, Foster Paul J, Jiang Yu, Pardeshi Anmol A, Jiang Yuzhen et al.

This study found superior LPI location significantly widened the angle more than temporal/nasal LPI in PACS patients, suggesting superior placement optimizes anatomical outcomes.

Liao Chimei, Zhang Jian, Jiang Yuzhen, Huang Shengsong, Aung Tin, Foster Paul J et al.

YAG LPI in PACS patients showed minimal, non-clinically significant corneal endothelial cell loss over 72 months, suggesting its long-term safety for corneal health.

He Mingguang, Jiang Yuzhen, Huang Shengsong, Chang Dolly S, Munoz Beatriz, Aung Tin et al.

This study found prophylactic laser iridotomy modestly reduced angle-closure disease in suspects, but the overall low incidence means widespread treatment isn't recommended due to limited benefit.

Friedman David S, Chang Dolly Shuo-Teh, Jiang Yuzhen, Huang Shengsong, Kong Xiangbin, Munoz Beatriz et al.

Darkroom prone provocative testing poorly distinguished angle closure suspects from controls, and didn't predict future glaucoma, limiting its clinical utility for risk assessment.

Konstantakopoulou Evgenia, Gazzard Gus, Vickerstaff Victoria, Jiang Yuzhen, Nathwani Neil, Hunter Rachael et al.

The LiGHT trial compared initial SLT versus medication for glaucoma/OHT, finding baseline patient characteristics were consistent with other studies, paving the way for crucial real-world treatment efficacy and cost-effectiveness comparisons.

Chong Rachel S, Su Daniel H W, Tsai Andrew, Jiang Yuzhen, Htoon Hla Myint, Lamoureux Ecosse L et al.

Glaucoma patients largely accept 3-monthly subconjunctival injections, especially those with complex regimens or nonadherence, suggesting a promising alternative to improve medication compliance.

Day Alexander C, Garway-Heath David F, Broadway David C, Jiang Yuzhen, Hayat Shabina, Dalzell Nichola et al.

OCT imaging in older adults showed aqueous outflow structure dimensions correlate with age, intraocular pressure, and ocular biometry. This helps understand glaucoma risk factors.

Jiang Yuzhen, Chang Dolly S, Foster Paul J, He Mingguang, Huang Shengsong, Aung Tin et al.

LPI in angle-closure suspects caused a significant, mostly transient IOP rise in 9.8% at 1 hour, rarely requiring intervention, with higher risk linked to more laser energy and shallower anterior chambers.

Jiang Yuzhen, He Mingguang, Huang Wenyong, Huang Qunxiao, Zhang Jian, Foster Paul J

This study used UBM to compare narrow and wide angles, finding basal iris thickness, not overall iris thickness, is more relevant to narrow angle configuration, aiding understanding of angle closure.

Okeke Constance O, Quigley Harry A, Jampel Henry D, Ying Gui-shuang, Plyler Ryan J, Jiang Yuzhen et al.

A multifaceted intervention significantly improved adherence to once-daily glaucoma drops in non-adherent patients, highlighting that targeted support can boost medication use.

Friedman David S, Okeke Constance O, Jampel Henry D, Ying Gui-shuang, Plyler Ryan J, Jiang Yuzhen et al.

This study found that younger/older age, African American race, and poorer self-reported health are risk factors for poor adherence to daily glaucoma eyedrops, highlighting patient-specific adherence challenges.

Okeke Constance O, Quigley Harry A, Jampel Henry D, Ying Gui-shuang, Plyler Ryan J, Jiang Yuzhen et al.

Electronic monitoring of glaucoma drop use revealed nearly 45% of patients were poorly adherent, often over-reporting use, highlighting the challenge for clinicians to identify non-adherence.